Inventaire - teman dan komunitas anda adalah perpustakaan terbaik

Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years

pengarang

Riccardo Haupt

Milen Minkov

Gritta Janka

R Maarten Egeler

1955 -

diterbitkan dalam: Pediatric Blood Cancer

tanggal publikasi: 2012-10-25

subyek utama: Pasien, Langerhans cell histiocytosis specific to childhood

Cites articles 55

Date

Judul

Pengarang

2012

B-RAF mutant alleles associated with Langerhans cell histiocytosis, a granulomatous pediatric disease

Franca Fraternali, Frederic Geissmann, Syed A Mian
2012-01-28

Pulmonary involvement in pediatric-onset multisystem Langerhans cell histiocytosis: effect on course and outcome

Ulrike Pötschger, Milen Minkov, Gritta Janka
2012-08-09

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.

Felix Sahm, David Launay, Andreas von Deimling, Zahir Amoura, Julien Haroche
2011-12-12

Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective study

Nadine Martin-Duverneuil, Anne-Sophie Defachelles, Anne Lambilliotte, Corinne Armari-Alla, Gérard Couillault, Martine Munzer
2011-07-30

GRADE guidelines: 9. Rating up the quality of evidence

Shahnaz Sultan, Victor Montori, Mohammad Murad, Pablo Alonso-Coello, Elie A Akl, Joerg J Meerpohl, Paul P. Glasziou, Gordon Guyatt, Andrew D. Oxman, Gunn Elisabeth Vist, Jan Brozek, Holger Schünemann, Susan L. Norris, el GRADE Working Group, Yngve Falck-Ytter, Roman Jaeschke, David Rind
2011-01-16

The current status of follow-up services for childhood cancer survivors, are we meeting goals and expectations: a report from the Consortium for New England Childhood Cancer Survivors

Nina Kadan-Lottick
2011-01-11

Fifteen years of treatment with intravenous immunoglobulin in central nervous system Langerhans cell histiocytosis

Désirée Gavhed, Jan-Inge Henter
2010-09-16

Recurrent BRAF mutations in Langerhans cell histiocytosis

Mark D Fleming, Matthew Meyerson, Levi A Garraway, William C Hahn, Jo-Anne Vergilio, Gayane Badalian-Very, Barbara A. Degar, Barrett J Rollins
2010-06-01

Central nervous system disease in Langerhans cell histiocytosis.

Kenneth L McClain, Jan-Inge Henter, Hans Lassmann
2010-03

Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside

Maxine L. Hetherington
2010-03-01

Bone marrow findings at diagnosis in patients with multisystem langerhans cell histiocytosis
2009-09-01

Development of a brief ataxia rating scale (BARS) based on a modified form of the ICARS.

Jeremy D. Schmahmann
2009-12-01

2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society

Ulrike Pötschger
2009-02-01

Cholesteatoma secondary to temporal bone involvement by Langerhans cell histiocytosis: a complication amenable to curative surgery

Nicolas Leboulanger, Eréa-Noel Garabedian
2009-01-01

Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis
2008-04-26

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

Pablo Alonso-Coello, Gordon Guyatt, Andrew D. Oxman, Gunn Elisabeth Vist, Holger Schünemann
2008-04-01

Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders
2008-01-01

Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine

Ira J Dunkel, Jeffrey Allen
2007-12-18

Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification.

Ulrike Pötschger, Milen Minkov, Jan-Inge Henter
2007-10-01

Bone marrow assessment in Langerhans cell histiocytosis

Ulrike Pötschger, Milen Minkov
2007-01-01

A phase II trial using thalidomide for Langerhans cell histiocytosis

Kenneth L McClain
2006-01-06

Caring for survivors of childhood cancers: the size of the problem
2006-02-01

Risk factors for diabetes insipidus in langerhans cell histiocytosis

Ulrike Pötschger, Milen Minkov, Jan-Inge Henter, Maurizio Aricò
2006-09-07

Long term morbidity and health related quality of life after multi-system Langerhans cell histiocytosis.

Adam W. Glaser
2005-04-07

Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction
2005-08-01

Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning
2005-03-01

Langerhans cell histiocytosis with central nervous system involvement: follow-up by FDG-PET during treatment with cladribine

Tomas Buchler, Otakar Bělohlávek
2004-12-01

Outcome in children with pulmonary Langerhans cell Histiocytosis.
2004-07-01

Retinoic acid therapy in "degenerative-like" neuro-langerhans cell histiocytosis: a prospective pilot study

Frederic Geissmann, Olivier Hermine, Ahmed Idbaih
2004-05-01

Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group

Riccardo Haupt, Kenneth L McClain, Gritta Janka-Schaub
2004

A New clinical score for disease activity in Langerhans cell histiocytosis

Olivier Hermine
2004-11-08

Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders

Artikel - wd:Q34308876

Selamat datang di Inventaire

perpustakaan teman-teman dan komunitas anda

pelajari lebih lanjut